Rackliffe Philip (CIK 2027284) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-04). Recent activity: Sell GEHC (798 shares), Sell GEHC (290 shares), Sell GEHC (226 shares), Sell GEHC (340 shares), Buy GEHC (16,458 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | GE HealthCare Technologies Inc. (GEHC) | CEO, AIS | Sell | 798 | $56,307 |
| 2026-09-03 | GE HealthCare Technologies Inc. (GEHC) | CEO, AIS | Sell | 290 | $20,657 |
| 2026-09-03 | GE HealthCare Technologies Inc. (GEHC) | CEO, AIS | Sell | 226 | $16,098 |
| 2026-09-03 | GE HealthCare Technologies Inc. (GEHC) | CEO, AIS | Sell | 340 | $24,218 |
| 2026-05-19 | GE HealthCare Technologies Inc. (GEHC) | CEO, AIS | Buy | 16,458 | $0 |
| 2026-03-04 | GE HealthCare Technologies Inc. (GEHC) | CEO, AVS | Buy | 9,356 | $0 |
| 2026-02-17 | GE HealthCare Technologies Inc. (GEHC) | CEO, AVS | Buy | 3,154 | $0 |
| 2026-02-17 | GE HealthCare Technologies Inc. (GEHC) | CEO, AVS | Sell | 1,174 | $92,981 |
| 2026-02-03 | GE HealthCare Technologies Inc. (GEHC) | CEO, AVS | Sell | 189 | $14,925 |
| 2025-09-03 | GE HealthCare Technologies Inc. (GEHC) | CEO, AVS | Sell | 165 | $12,165 |
| 2025-09-03 | GE HealthCare Technologies Inc. (GEHC) | CEO, AVS | Sell | 134 | $9,880 |
| 2025-09-03 | GE HealthCare Technologies Inc. (GEHC) | CEO, AVS | Sell | 204 | $15,041 |
| 2025-09-03 | GE HealthCare Technologies Inc. (GEHC) | CEO, AVS | Sell | 1,388 | $102,337 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04